On Monday, Clover Health Investments Corp (NASDAQ: CLOV) opened higher 2.20% from the last session, before settling in for the closing price of $3.64. Price fluctuations for CLOV have ranged from $0.61 to $4.71 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 52.25% annually for the last half of the decade. Company’s average yearly earnings per share was noted 73.20% at the time writing. With a float of $376.28 million, this company’s outstanding shares have now reached $394.44 million.
In an organization with 552 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 33.96%, operating margin of -5.84%, and the pretax margin is -6.21%.
Clover Health Investments Corp (CLOV) Insider Updates
A key investor’s attitude towards the stock of the Healthcare Plans industry is another important factor to consider. The insider ownership of Clover Health Investments Corp is 24.62%, while institutional ownership is 16.44%. The most recent insider transaction that took place on Aug 09 ’24, was worth 999,596. In this transaction Director of this company bought 531,700 shares at a rate of $1.88, taking the stock ownership to the 1,409,267 shares. Before that another transaction happened on Jun 17 ’24, when Company’s Director bought 877,567 for $1.14, making the entire transaction worth $1,000,426. This insider now owns 877,567 shares in total.
Clover Health Investments Corp (CLOV) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 73.20% per share during the next fiscal year.
Clover Health Investments Corp (NASDAQ: CLOV) Trading Performance Indicators
Check out the current performance indicators for Clover Health Investments Corp (CLOV). In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.19, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.14 in one year’s time.
Technical Analysis of Clover Health Investments Corp (CLOV)
Let’s dig in a bit further. During the last 5-days, its volume was 7.21 million. That was better than the volume of 6.45 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 85.35%. Additionally, its Average True Range was 0.20.
During the past 100 days, Clover Health Investments Corp’s (CLOV) raw stochastic average was set at 56.10%, which indicates a significant decrease from 74.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.28% in the past 14 days, which was lower than the 77.29% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.42, while its 200-day Moving Average is $2.29. However, in the short run, Clover Health Investments Corp’s stock first resistance to watch stands at $3.89. Second resistance stands at $4.05. The third major resistance level sits at $4.17. If the price goes on to break the first support level at $3.61, it is likely to go to the next support level at $3.49. Assuming the price breaks the second support level, the third support level stands at $3.33.
Clover Health Investments Corp (NASDAQ: CLOV) Key Stats
There are currently 501,109K shares outstanding in the company with a market cap of 1.86 billion. Presently, the company’s annual sales total 2,034 M according to its annual income of -213,360 K. Last quarter, the company’s sales amounted to 330,990 K and its income totaled -9,160 K.
